Insulet (Nasdaq:PODD) shared new clinical evidence for its first fully closed-loop automated insulin delivery system for type 2 diabetes.
Abstract: This paper presents a residue amplifier scheme consisting of a high-speed current-steering (CS) digital-to-analog converter (DAC) and a wideband active back-biased open-loop amplifier. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results